Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)
Phase 1 / Phase 2 · 1 site
Search the registry
2,585 studies found
Phase 1 / Phase 2 · 1 site
Phase 3 · 1 site
Phase 2 / Phase 3 · 9 sites
Potential match only. Final eligibility is determined by the study team.